Kelsey Browne Email Address

President and Chief Executive Officer

Revance is committed to the advancement of remarkable science that improves patient outcomes.

Dan Browne s a co-founder of Revance Therapeutics, Inc., and has served as its President and Chief Executive Officer and as a Board member since inception of the company in 2002, through the company’s successful IPO and follow-on transactions in 2014. Revance is a specialty pharmaceutical company that is developing neuromodulation products that are designed to transform a growing, multi-billion dollar botulinum toxin market. Revance is committed to bringing to market novel botulinum toxin products that address the limitations of currently available neurotoxins. The company’s lead investigational product is a topical, targeted, no-needle formulation of botulinum toxin type A (BoNTA) with a broad pipeline of potential cosmetic and therapeutic indications. Revance is also developing a next generation botulinum toxin product designed for longer duration of effect and greater control of diffusion compared to other existing injectable botulinum toxin products. Dan Browne has more than 25 years of executive leadership experience and has served as President & CEO for three pharmaceutical/medical technology companies and has led the development of multiple products and technologies that are leaders in their category. Specific experience includes:REVANCE THERAEPUTICS:-Founded company and led initial investment round in 2002 and first venture financing in 2004-Raised more than $200 million in private investment-Took company public via initial public offering in 2014-Raised more than $240 million in public capital in IPO and follow-on financingsPRIOR EXECUTIVE EXPERIENCE and P&L RESPONSIBILITIES:-Served as President & CEO of Neomend, Inc. -Served as President & CEO of Prograft Medical, Inc.-Served as Business Leader of Gore Interventional Products-Served as Global Business Unit Product Specialist of W.L. Gore’s Medical Products Division with responsibilities for product research & development, manufacturing, quality, and sales and marketing.